Peptide ELISA: Limit Dilution: 1/4000. Western blot: 1-3 μg/mL. Approx 50-55 kDa band observed in Human Testis, MOLT-4 andJurkat lysates (predicted MW of 55 kDa according to NP_055428). Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Konzentration
0.5 mg/mL
Buffer
Tris saline, pH 7.3 containing 0.02 % Sodium Azide as preservative and 0.5 % BSA as stabilizer.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handhabung
Avoid repeated freezing and thawing.
Lagerung
4 °C/-20 °C
Informationen zur Lagerung
Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
Target
FAF2
(Fas Associated Factor Family Member 2 (FAF2))
FAF2 antikoerper, UBXD8 antikoerper, ETEA antikoerper, UBXN3B antikoerper, 2210404D11Rik antikoerper, AI462440 antikoerper, Ubxd8 antikoerper, mKIAA0887 antikoerper, 2210404d11rik antikoerper, RGD1306577 antikoerper, UBX8 antikoerper, etea antikoerper, ubxd8 antikoerper, ubxn3b antikoerper, Fas associated factor family member 2 antikoerper, Fas associated factor family member 2 S homeolog antikoerper, FAF2 antikoerper, Faf2 antikoerper, faf2.S antikoerper
Hintergrund
ETEA protein is highly expressed in peripheral blood of patients with atopic dermatitis (AD), compared to normal individuals. It may play a role in regulating the resistance to apoptosis that is observed in T cells and eosinophils of AD patients.Synonyms: FAS-associated factor 2, KIAA0887, UBX domain-containing protein 3B, UBX domain-containing protein 8, UBXD8, UBXN3B